Back to MIRM
GOLDMAN SACHS GROUP INC → MIRM
GOLDMAN SACHS GROUP INC MIRM Position History
Mirum Pharmaceuticals, Inc. • Healthcare
Quarters held
15
Latest value
$253K
Q2 2026
Peak value
$54.3M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $17.1M |
| Q2 2025 | $3M |
| Q3 2025 | $28.6M |
| Q3 2025 | $4.5M |
| Q4 2025 | $229K |
| Q4 2025 | $25.3M |
| Q4 2025 | $31.7M |
| Q4 2025 | $31.7M |
| Q4 2025 | $25.3M |
| Q4 2025 | $229K |
| Q1 2026 | $50.6M |
| Q1 2026 | $10.6M |
| Q2 2026 | $54.3M |
| Q2 2026 | $9.8M |
| Q2 2026 | $253K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $253K | 2.2K | — | — |
| Q2 2026 | $9.8M | 83.5K | — | — |
| Q2 2026 | $54.3M | 464.2K | — | — |
| Q1 2026 | $10.6M | 115.0K | — | — |
| Q1 2026 | $50.6M | 547.3K | — | — |
| Q4 2025 | $229K | 2.9K | — | — |
| Q4 2025 | $25.3M | 319.7K | — | — |
| Q4 2025 | $31.7M | 401.7K | — | — |
| Q4 2025 | $31.7M | 401.7K | — | — |
| Q4 2025 | $25.3M | 319.7K | — | — |
| Q4 2025 | $229K | 2.9K | — | — |
| Q3 2025 | $4.5M | 61.2K | — | — |
| Q3 2025 | $28.6M | 389.7K | — | — |
| Q2 2025 | $3M | 58.5K | — | — |
| Q2 2025 | $17.1M | 336.5K | — | — |
Other funds holding MIRM
$254.1M
$254.1M
$179.6M
$91.6M
$61.4M